Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
February 7, 2018
AUDENTES THERAPEUTICS ANNOUNCES SELECTION OF OPTIMIZED CLINICAL DEVELOPMENT CANDIDATE FOR POMPE DISEASE PROGRAM
February 1, 2018
CHRONO THERAPEUTICS ANNOUNCES APPOINTMENT OF DAVID HAPPEL AS CHIEF EXECUTIVE OFFICER
February 1, 2018
CETERIX ANNOUNCES COMPLETION OF GROUNDBREAKING STUDY OF REPAIR FOR MENISCAL TEARS PREVIOUSLY THOUGHT UNREPAIRABLE
January 29, 2018
AUDENTES THERAPEUTICS ANNOUNCES THE CLOSING OF ITS PUBLIC OFFERING AND FULL EXERCISE OF THE UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES
January 25, 2018
AUDENTES THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
January 25, 2018
VENTUREFORWARD BLOG SERIES: DIVERSITY BREEDS DIVERSITY BY 5AM’S ANDY SCHWAB
January 24, 2018
NOHLA THERAPEUTICS GRANTED ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR NLA101 IN THE TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
January 23, 2018
AUDENTES THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
January 17, 2018
HOMOLOGY MEDICINES APPOINTS MATTHEW R. PATTERSON TO BOARD OF DIRECTORS
January 8, 2018
NOHLA THERAPEUTICS ANNOUNCES HIRING OF JIM JOHNSON AS CHIEF FINANCIAL OFFICER
« Previous Page
1
…
64
65
66
67
68
…
103